GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 1 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $768,000 | -12.6% | 13,928 | 0.0% | 0.11% | -13.0% |
| Q2 2020 | $879,000 | +23.5% | 13,928 | 0.0% | 0.12% | +16.0% |
| Q1 2020 | $712,000 | -35.7% | 13,928 | 0.0% | 0.11% | -81.8% |
| Q4 2019 | $1,107,000 | +63.8% | 13,928 | 0.0% | 0.58% | -54.9% |
| Q3 2019 | $676,000 | -7.8% | 13,928 | 0.0% | 1.29% | -37.5% |
| Q2 2019 | $733,000 | +8.9% | 13,928 | 0.0% | 2.07% | +30.7% |
| Q1 2019 | $673,000 | +17.7% | 13,928 | 0.0% | 1.58% | +14.5% |
| Q4 2018 | $572,000 | +8.1% | 13,928 | 0.0% | 1.38% | +34.4% |
| Q3 2018 | $529,000 | -16.0% | 13,928 | 0.0% | 1.03% | -37.5% |
| Q2 2018 | $630,000 | -6.4% | 13,928 | 0.0% | 1.65% | +33.5% |
| Q1 2018 | $673,000 | +22.8% | 13,928 | 0.0% | 1.23% | +49.4% |
| Q4 2017 | $548,000 | – | 13,928 | – | 0.83% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |